American Optometric Association

Published on December 17, 2025
Change Agent Scott Gibbons, O.D., shares his thoughts on pediatric eye health and The Myopia Collective. Read more on how The Myopia Collective harnesses advocacy efforts to drive meaningful...
Continue reading on website
Other news

Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis | Optometry Times - Clinical News

December 16, 2025
Isocyclosporin is a dual inhibitor of transient receptor potential cation channel, mucolipin subfamily, member 2 (TRPML2), and calcineurin.

Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA | Optometry Times - Clinical News

December 17, 2025
K8 is a member of a new class of inflammasome-inhibiting drugs called kamuvudines.